Branch² Intelligence
Biocon among 4 midcap stocks that hit 52-week highs and rallied up to 21% in a month
Key takeaway
Four BSE 150 Midcap stocks hit 52-week highs despite a declining Sensex, signaling strong sector-specific buying.
- Step 1Biocon and three other midcaps hit 52-week highs on strong buying interest.
- Step 2The rally improves Biocon's market cap and equity valuation, lowering its cost of equity capital.
- Step 3Lower cost of capital enables Biocon to invest more in R&D and manufacturing, benefiting its SME contract manufacturers and suppliers.
Source: IN:Economic Times
This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.